BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 23104101)

  • 1. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuins--novel therapeutic targets to treat age-associated diseases.
    Lavu S; Boss O; Elliott PJ; Lambert PD
    Nat Rev Drug Discov; 2008 Oct; 7(10):841-53. PubMed ID: 18827827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiology of sirtuins and their role in neurodegeneration.
    Donmez G
    Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic benefits from Sirt1 and Sirt1 activators.
    Chaudhary N; Pfluger PT
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):431-7. PubMed ID: 19474719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuins Function as the Modulators in Aging-related Diseases in Common or Respectively.
    Wang QL; Guo SJ
    Chin Med J (Engl); 2015 Jun; 128(12):1671-8. PubMed ID: 26063372
    [No Abstract]   [Full Text] [Related]  

  • 6. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
    Albani D; Polito L; Forloni G
    J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuins, aging, and metabolism.
    Guarente L
    Cold Spring Harb Symp Quant Biol; 2011; 76():81-90. PubMed ID: 22114328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sirtuin family: therapeutic targets to treat diseases of aging.
    Milne JC; Denu JM
    Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuins in aging and disease.
    Guarente L
    Cold Spring Harb Symp Quant Biol; 2007; 72():483-8. PubMed ID: 18419308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin activators and inhibitors.
    Villalba JM; Alcaín FJ
    Biofactors; 2012; 38(5):349-59. PubMed ID: 22730114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuins in gamete biology and reproductive physiology: emerging roles and therapeutic potential in female and male infertility.
    Tatone C; Di Emidio G; Barbonetti A; Carta G; Luciano AM; Falone S; Amicarelli F
    Hum Reprod Update; 2018 May; 24(3):267-289. PubMed ID: 29447380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecules as SIRT Modulators.
    Bai X; Yao L; Ma X; Xu X
    Mini Rev Med Chem; 2018; 18(13):1151-1157. PubMed ID: 27334466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sirtuins--modulation of their activity as a novel therapeutic target].
    Kucińska M; Piotrowska H; Murias M
    Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
    Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
    Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Huber K; Superti-Furga G
    Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and disease: connections to sirtuins.
    Donmez G; Guarente L
    Aging Cell; 2010 Apr; 9(2):285-90. PubMed ID: 20409078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins.
    Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y
    Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuins: novel targets for metabolic disease.
    Elliott PJ; Jirousek M
    Curr Opin Investig Drugs; 2008 Apr; 9(4):371-8. PubMed ID: 18393104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.